UNKNOWN_NEUROVASCULAR_PRODUCT
Report
- Report Number
- 3008853977-2014-00332
- Event Type
- Injury
- Date Received
- October 15, 2014
- Date of Event
- August 1, 2013
- Report Date
- September 29, 2014
- Manufacturer
- STRYKER NEUROVASCULAR-UTAH
- Product Code
- DQX
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- PHYSICIAN
Narratives
THE DEVICE WAS NOT AVAILABLE FOR ANALYSIS. FROM THE INFORMATION PROVIDED THERE WAS NO INDICATION THAT THE DEVICE WAS NOT USED AS IN ACCORDANCE WITH THE LABELING OR THAT THIS CAUSED OR CONTRIBUTED TO THE REPORTED EVENT. VESSEL VASOSPASM, HEMORRHAGE, STROKE, HEADACHE AND NEUROLOGICAL DEFICIT ARE KNOWN AND ANTICIPATED COMPLICATIONS TO THESE TYPES OF PROCEDURES AND ARE NOTED IN THE LABELING. THEREFORE, IT WAS DETERMINED THAT THE REPORTED EVENT WAS AN ANTICIPATED PROCEDURAL COMPLICATION.
EVENT DATE: THE EXACT DATE OF THE ADVERSE EVENT IS UNKNOWN. THE DEVICE IS NOT AVAILABLE TO THE MANUFACTURER.
IT WAS REPORTED IN THE LITERATURE ARTICLE THAT THE SUBJECT GUIDEWIRE WAS UNEVENTFULLY DELIVERED IN THE P1 SEGMENT OF THE LEFT POSTERIOR CEREBRAL ARTERY (PCA) AND ANGIOPLASTY WAS PERFORMED TO TREAT THE BA STENOSIS. HOWEVER, DURING THE RETRIEVAL OF THE DEVICE, THE GUIDEWIRE TIP WAS TRAPPED IN THE LEFT PI PCA LUMEN. IT WAS THOUGHT THAT THE ENTRAPMENT OF THE SUBJECT DEVICE MAY HAVE BEEN CAUSED BY A VESSEL SPASM; SO PAPAVERINE (10 MG OVER 3¿4 MIN) AND NIMODIPINE (1 MG OVER 10 MIN) WERE ADMINISTERED INTRA-ARTERIALLY, BUT THIS DID NOT RESULT IN THE SUCCESSFUL RETRIEVAL OF THE DEVICE. THE PROCEDURE WAS COMPLETED WITH PLACEMENT OF A NON-STRYKER STENT ACROSS THE TARGET LESION. COMPLETE REVASCULARIZATION OF THE BA WAS ACHIEVED WITH A THROMBOLYSIS IN CEREBRAL INFARCTION (TICI) SCORE OF 3. THEN THE DECISION WAS MADE TO LEAVE THE TRAPPED DEVICE IN PLACE TEMPORARILY FOR 1 DAY CONSIDERING THAT AGGRESSIVE RETRIEVAL PROCEDURE COULD CAUSE THE CEREBRAL VASCULATURE INJURY. AT THE TIME OF CONSCIOUSNESS RECOVERY, THE PATIENT HAD A HEADACHE, DOUBLE VISION AND HEMIPARESIS OF THE RIGHT LIMB. IMAGING IDENTIFIED A SUBARACHNOID HEMORRHAGE (SAH) AT THE INTERPEDUNCULAR CISTERN AND THIS MAY BE RELATED TO THE RUPTURE OF PERFORATOR ARTERIES. THE NEXT MORNING THE PATIENT¿S HEADACHE HAD DISAPPEARED AND IMAGING SHOWED IMPROVEMENT OF THE SAH. THE GUIDEWIRE WAS INADVERTENTLY DISLOCATED FROM THE LEFT PCA DURING MANIPULATION USING A LOOPED CATHETER AND COMPLETELY REMOVED FROM THE PATIENT. IMAGING SHOWED THE SAH SIZE WAS SLIGHTLY INCREASED AFTER THE DEVICE WAS REMOVED BUT THE PATIENT¿S SYMPTOMS REMAINED STABLE. THE PATIENT WAS ASYMPTOMATIC 10 DAYS LATER AND DISCHARGED HOME.
IT WAS REPORTED IN THE LITERATURE ARTICLE THAT THE SUBJECT GUIDEWIRE WAS UNEVENTFULLY DELIVERED IN THE P1 SEGMENT OF THE LEFT POSTERIOR CEREBRAL ARTERY (PCA) AND ANGIOPLASTY WAS PERFORMED TO TREAT THE BA STENOSIS. HOWEVER, DURING THE RETRIEVAL OF THE DEVICE, THE GUIDEWIRE TIP WAS TRAPPED IN THE LEFT PI PCA LUMEN. IT WAS THOUGHT THAT THE ENTRAPMENT OF THE SUBJECT DEVICE MAY HAVE BEEN CAUSED BY A VESSEL SPASM; SO PAPAVERINE (10 MG OVER 3¿4 MIN) AND NIMODIPINE (1 MG OVER 10 MIN) WERE ADMINISTERED INTRA-ARTERIALLY, BUT THIS DID NOT RESULT IN THE SUCCESSFUL RETRIEVAL OF THE DEVICE. THE PROCEDURE WAS COMPLETED WITH PLACEMENT OF A NON-STRYKER STENT ACROSS THE TARGET LESION. COMPLETE REVASCULARIZATION OF THE BA WAS ACHIEVED WITH A THROMBOLYSIS IN CEREBRAL INFARCTION (TICI) SCORE OF 3. THEN THE DECISION WAS MADE TO LEAVE THE TRAPPED DEVICE IN PLACE TEMPORARILY FOR 1 DAY CONSIDERING THAT AGGRESSIVE RETRIEVAL PROCEDURE COULD CAUSE THE CEREBRAL VASCULATURE INJURY. AT THE TIME OF CONSCIOUSNESS RECOVERY, THE PATIENT HAD A HEADACHE, DOUBLE VISION AND HEMIPARESIS OF THE RIGHT LIMB. IMAGING IDENTIFIED A SUBARACHNOID HEMORRHAGE (SAH) AT THE INTERPEDUNCULAR CISTERN AND THIS MAY BE RELATED TO THE RUPTURE OF PERFORATOR ARTERIES. THE NEXT MORNING THE PATIENT¿S HEADACHE HAD DISAPPEARED AND IMAGING SHOWED IMPROVEMENT OF THE SAH. THE GUIDEWIRE WAS INADVERTENTLY DISLOCATED FROM THE LEFT PCA DURING MANIPULATION USING A LOOPED CATHETER AND COMPLETELY REMOVED FROM THE PATIENT. IMAGING SHOWED THE SAH SIZE WAS SLIGHTLY INCREASED AFTER THE DEVICE WAS REMOVED BUT THE PATIENT¿S SYMPTOMS REMAINED STABLE. THE PATIENT WAS ASYMPTOMATIC 10 DAYS LATER AND DISCHARGED HOME.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 654777 | UNKNOWN_NEUROVASCULAR_PRODUCT | WIRE, GUIDE, CATHETER | DQX | STRYKER NEUROVASCULAR-UTAH |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 64 YR | Required Intervention | GATEWAY BALLOON CATHETER (BOSTON SCIENTIFIC) |